Chronic kidney disease as a cardiovascular risk factor

American Heart Journal

Volumn 145, Issue 3, 2003, Pages 383-386

  Best, Patricia J M ^a   Holmes Jr , David R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOCARDIOGRAPHY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; EDITORIAL; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SURVIVAL RATE;

EID: 0037352182     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.122     Document Type: Editorial

References (26)

1. US Renal Data System. USRDS 2000 annual data report. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2000.
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(3 Suppl):S112-9.
3. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998;339:799-805.
4. Herzog CA. Acute myocardial infarction in patients with end-stage renal disease. Kidney Int 1999;71:S130-3.
5. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;35(1 Suppl):S117-31.
6. Ting HH, Tahirkheli NK, Berger PB, et al. Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure. Am J Cardiol 2001;87:630-3.
7. Levin A, Djurdjev O, Barrett B, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kid Dis 2001;38:398-407.
8. Jungers P, Massy Z, Khoa T, et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997;12:2597-602.
9. Tonelli M, Bohm C, Pandeya S, et al. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kid Dis 2001;36(6 Suppl 3):S24-30.
10. Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002;39:1113-9.
11. Schillaci G, Reboldi G, Verdecchia P. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Int Med 2001;161:886-91.
12. Reis SE, Olson MB, Fried L, et al. Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation 2002;105:2826-9.
13. Szczech LA, Best PJ, Crowley E, et al. Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation 2002;105:2253-8.
14. Anonymous. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002;39(2 Suppl):S1-246.
15. Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Int Med 2001;161:1207-16.
16. Jones CA, McQuillan GM, Kusek JW, et al. Serum creatinine levels in the US population: third Nationol Health and Nutrition Examination Survey. Am J Kidney Dis 1998;32:992-9.
17. Kasiske BL. Hyperlipidemia in patients with chronic renal disease. Am J Kid Dis 1998;32(3 Suppl):S142-56.
18. Cressman MD, Heyka RJ, Paganini EP, et al. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992;86:475-82.
19. Pinto-Sietsma SJ, Mulder J, Janssen WM, et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Int Med 2000;133:585-91.
20. Gatling W, Mullee MA, Knight C, Hill RD. Microalbuminuria in diabetes: relationships between urinary albumin excretion and diabetes-related variables. Diabet Med 1988;5:348-51.
21. Biesenbach G, Zazgornik J. Influence of smoking on the survival rate of diabetic patients requiring hemodialysis. Diabetes Care 1996;19:625-8.
22. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:23-33.
23. Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000;356:1213-8.
24. Hase H, Imamura Y, Nakamura R, et al. Effects of rHuEPO therapy on exercise capacity in hemodialysis patients with coronary artery disease. Jpn Circ J 1993;57:131-7.
25. Wizemann V, Kaufmann J, Kramer W. Effect of erythrapaietin on ischemia tolerance in anemic hemodialysis patients with confirmed coronary artery disease. Nephron 1992;62:161-5.
26. Sommerburg O, Grune T, Hampl H, et al. Does treatment of renal anemia with recombinant erythrapoietin influence oxidative stress in hemodialysis patients? Clin Nephrol 2000;53(1 Suppl):S23-9.